The link you have chosen leads to a site maintained by a third party over whom Bracco Imaging has no control. As such, Bracco Imaging makes no representation as to the accuracy or any other aspect of the information on this site. The clinical use of Bracco Imaging Products in these pages may not be consistent with the approved indications.
The information on this site is not country specific and may contain information that is outside the approved indication where you practice.
Please contact your local Bracco Imaging representative for the latest Bracco Imaging product information specific to your country.
2022
-
Wednesday, 30 March 2022
Gadopiclenol: another milestone achieved
2020
-
Monday, 27 April 2020
Bracco Launches Global “BRACCO CARES” Initiative to Support Healthcare Professionals Through Trying Times -
Thursday, 30 January 2020
Bracco named a 2020 Top Employer Italia
2019
-
Thursday, 27 June 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics with the Acquisition of Blue Earth Diagnostics
2018
-
Tuesday, 31 July 2018
Bracco Imaging collaborates with a major academic medical center on improving patient care through new protocols for Computed Tomography (CT) imaging -
Wednesday, 20 June 2018
Bracco's Ultrasound Contrast Agent receives approval in China for intravesical use in ultrasonography of the excretory tract -
Tuesday, 22 May 2018
Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound -
Saturday, 3 March 2018
Bracco Imaging reinforces its portfolio in Interventional Oncology -
Tuesday, 23 January 2018
Bracco Imaging reinforces its commitment to innovation in ultrasound -
Tuesday, 23 January 2018
Bracco Imaging reinforces its commitment to innovation in ultrasound
2017
-
Wednesday, 18 October 2017
Bracco expands into the Fluorescence Guided Surgery field through the acquisition of SurgVision -
Monday, 24 July 2017
Public statement of Bracco Imaging with regard to the European Medicine Agency’s Final Opinion on Gadolinium-Based Contrast Agents -
Friday, 7 July 2017
Public statement of Bracco Imaging with regard to the Pharmacovigilance Risk Assessment Committee Final Recommendations on Gadolinium-Based Contrast Agents -
Tuesday, 4 April 2017
Bracco Imaging reinforces its portfolio of Informatics Solutions for Radiology through a strategic investment in PHS Technologies Group
2016
-
Thursday, 15 September 2016
Bracco Imaging receives approval in Mexico for ultrasound contrast agent
2015
-
Wednesday, 3 June 2015
Bracco Imaging announces the first echocardiography imaging procedure in US with sulfur hexafluoride lipid-type A microspheres for injectable suspension
2014
-
Monday, 13 October 2014
A new comparative study of non-ionic macrocyclic MRI contrast agents. -
Tuesday, 23 September 2014
Bracco launches its Ultrasound Contrast Agent in Russia -
Thursday, 24 July 2014
EIB Lends EUR 100 Million for Investment In Research And Innovation By Bracco Imaging -
Monday, 9 June 2014
Bracco Announces Labeling Change for its Ultrasound Contrast Agent in the European Union -
Monday, 28 April 2014
Bracco Imaging expands its Global MRI franchise -
Thursday, 6 March 2014
Bracco Imaging launches the new Tailored Protocol Software -
Wednesday, 5 March 2014
Newly published breast MRI data at ECR2014
2013
-
Monday, 30 September 2013
Bracco Imaging receives ANVISA approval in Brazil for ultrasound contrast agent -
Monday, 11 March 2013
Bracco receives MHRA approval for expanded labeling of gadobenate dimeglumine in Magnetic Resonance Imaging of the breast -
Thursday, 7 March 2013
MRI contrast agents compared at different doses
2012
-
Wednesday, 7 November 2012
High-Concentration CT Contrast Media and Lower Radiation Dose -
Tuesday, 18 September 2012
Bracco receives U.S. FDA approval for expanded labeling of gadobenate dimeglumine in Magnetic Resonance Angiography -
Thursday, 19 April 2012
Bracco Imaging announces a new direct presence in Argentina, Brazil and Mexico -
Thursday, 1 March 2012
Researchers find greater morphologic information and lesion enhancement with Bracco's MRI contrast agents
2011
-
Sunday, 27 November 2011
RSNA: Bracco Imaging Continues its Investment in Delivering Radiological Solutions -
Monday, 1 August 2011
Bracco Imaging acquires Swiss Medical Care -
Thursday, 3 March 2011
ECR 2011 Press Releases
2010
-
Sunday, 28 November 2010
Products, Services and Technologies Demonstrated at RSNA 2010 -
Thursday, 15 July 2010
Diana Bracco: "Research & Innovation: the key to Italy's future" -
Thursday, 15 July 2010
Two Researchers Awarded 2010 Bracco Diagnostics/RSNA Grants -
Friday, 11 June 2010
Imaging, crocevia della medicina - interview to Fulvio Renoldi Bracco, Head of the Global Business Unit Imaging, Il Sole 24 Ore speciale "Imaging - Evoluzioni nella diagnostica", Giugno 2010
2009
-
Friday, 27 March 2009
Princeton, NJ, Court Rules that GE Healthcare Engaged in False Advertising Campaign against Bracco Diagnostics -
Friday, 6 March 2009
Bracco Imaging attends ECR 2009 in Vienna and showcases expanded integrated imaging solutions portfolio -
Friday, 13 February 2009
Bracco Imaging opens its doors to all citizens
2008
-
Sunday, 30 November 2008
Bracco Imaging showcased expanded portfolio, integrated solution set at RSNA 2008 -
Friday, 24 October 2008
En 2008, Bracco Imaging s’implante en France -
Tuesday, 3 June 2008
Bracco Imaging al fianco dei giovani radiologi -
Wednesday, 2 April 2008
Neuer Firmenname für Bracco-Gesellschaft in Deutschland -
Tuesday, 1 April 2008
Merger of Bracco Diagnostics Inc. (BDI) with E-Z-EM enhances Bracco Group’s leadership in Diagnostic Imaging -
Friday, 7 March 2008
Bracco Imaging gets closer to its European customers enlarging its direct presence in Germany, France, Belgium, Luxemburg, and the Netherlands.
2007
-
Sunday, 25 November 2007
Bracco Diagnostics Inc. showcases its commitment to science and customers at RSNA 2007 -
Thursday, 8 November 2007
Healthtrust Purchasing Group and Bracco Diagnostics Inc. sign three-year agreement for X-Ray Contrast Media -
Thursday, 8 November 2007
Bracco Diagnostics Inc. receives 2007 Supplier Quality Award from Cardinal Health -
Tuesday, 30 October 2007
Bracco Diagnostics Inc. to acquire E-Z-EM
